Endothelial nitric oxide synthase protects neurons against ischemic injury through regulation of brain-derived neurotrophic factor expression. 2014

Shi-Ting Li, and Jing Pan, and Xu-Ming Hua, and Hong Liu, and Sa Shen, and Jia-Fu Liu, and Bin Li, and Bang-Bao Tao, and Xiao-Li Ge, and Xu-Hui Wang, and Juan-Hong Shi, and Xiao-Qiang Wang
Department of Neurosurgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

OBJECTIVE Several lines of evidence demonstrated that endothelial nitric oxide synthase (eNOS) confers protective effects during cerebral ischemia. In this study, we explored the underlying cellular and molecular mechanisms of neuroprotection by eNOS. METHODS A series of in vivo and in vitro ischemic models were employed to study the role of eNOS in maintaining neuronal survival and to identify the downstream factors. RESULTS The current data showed that pretreatment with a specific eNOS inhibitor, L-N5-(1-iminoethyl) ornithine (L-NIO), aggravated the neuronal loss in the rat cerebral ischemic model, accompanied by reduction in brain-derived neurotrophic factor (BDNF) level, which was consistent with the findings in an oxygen-glucose deprivation model (OGD) with two neuronal cells: primary rat cortical neurons and human neuroblastoma SH-SY5Y cells. Furthermore, the extensive neuronal loss induced by L-NIO was totally abolished by exogenous BDNF in both in vitro and in vivo models. On the other hand, eNOS overexpression through an adenoviral vector exerted a prominent protective effect on the neuronal cells subject to OGD, and the protective effect was totally abrogated by a neutralizing anti-BDNF antibody. CONCLUSIONS Collectively, our results indicate that the neuroprotection of neuron-derived eNOS against the cerebral ischemia was mediated through the regulation of BDNF secretion. In conclusion, our discovery provides a novel explanation for the neuroprotective effect of eNOS under pathological ischemic conditions such as stroke.

UI MeSH Term Description Entries
D008297 Male Males
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009952 Ornithine An amino acid produced in the urea cycle by the splitting off of urea from arginine. 2,5-Diaminopentanoic Acid,Ornithine Dihydrochloride, (L)-Isomer,Ornithine Hydrochloride, (D)-Isomer,Ornithine Hydrochloride, (DL)-Isomer,Ornithine Hydrochloride, (L)-Isomer,Ornithine Monoacetate, (L)-Isomer,Ornithine Monohydrobromide, (L)-Isomer,Ornithine Monohydrochloride, (D)-Isomer,Ornithine Monohydrochloride, (DL)-Isomer,Ornithine Phosphate (1:1), (L)-Isomer,Ornithine Sulfate (1:1), (L)-Isomer,Ornithine, (D)-Isomer,Ornithine, (DL)-Isomer,Ornithine, (L)-Isomer,2,5 Diaminopentanoic Acid
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D002546 Ischemic Attack, Transient Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6) Brain Stem Ischemia, Transient,Cerebral Ischemia, Transient,Crescendo Transient Ischemic Attacks,Transient Ischemic Attack,Anterior Circulation Transient Ischemic Attack,Brain Stem Transient Ischemic Attack,Brain TIA,Brainstem Ischemia, Transient,Brainstem Transient Ischemic Attack,Carotid Circulation Transient Ischemic Attack,Posterior Circulation Transient Ischemic Attack,TIA (Transient Ischemic Attack),Transient Ischemic Attack, Anterior Circulation,Transient Ischemic Attack, Brain Stem,Transient Ischemic Attack, Brainstem,Transient Ischemic Attack, Carotid Circulation,Transient Ischemic Attack, Posterior Circulation,Transient Ischemic Attack, Vertebrobasilar Circulation,Transient Ischemic Attacks, Crescendo,Vertebrobasilar Circulation Transient Ischemic Attack,Attack, Transient Ischemic,Attacks, Transient Ischemic,Brainstem Ischemias, Transient,Cerebral Ischemias, Transient,Ischemia, Transient Brainstem,Ischemia, Transient Cerebral,Ischemias, Transient Brainstem,Ischemias, Transient Cerebral,Ischemic Attacks, Transient,TIA, Brain,TIAs (Transient Ischemic Attack),Transient Brainstem Ischemia,Transient Cerebral Ischemia,Transient Cerebral Ischemias,Transient Ischemic Attacks
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

Shi-Ting Li, and Jing Pan, and Xu-Ming Hua, and Hong Liu, and Sa Shen, and Jia-Fu Liu, and Bin Li, and Bang-Bao Tao, and Xiao-Li Ge, and Xu-Hui Wang, and Juan-Hong Shi, and Xiao-Qiang Wang
March 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Shi-Ting Li, and Jing Pan, and Xu-Ming Hua, and Hong Liu, and Sa Shen, and Jia-Fu Liu, and Bin Li, and Bang-Bao Tao, and Xiao-Li Ge, and Xu-Hui Wang, and Juan-Hong Shi, and Xiao-Qiang Wang
January 2012, International journal of physiology, pathophysiology and pharmacology,
Shi-Ting Li, and Jing Pan, and Xu-Ming Hua, and Hong Liu, and Sa Shen, and Jia-Fu Liu, and Bin Li, and Bang-Bao Tao, and Xiao-Li Ge, and Xu-Hui Wang, and Juan-Hong Shi, and Xiao-Qiang Wang
July 2008, The Journal of veterinary medical science,
Shi-Ting Li, and Jing Pan, and Xu-Ming Hua, and Hong Liu, and Sa Shen, and Jia-Fu Liu, and Bin Li, and Bang-Bao Tao, and Xiao-Li Ge, and Xu-Hui Wang, and Juan-Hong Shi, and Xiao-Qiang Wang
January 2002, Acta oto-laryngologica,
Shi-Ting Li, and Jing Pan, and Xu-Ming Hua, and Hong Liu, and Sa Shen, and Jia-Fu Liu, and Bin Li, and Bang-Bao Tao, and Xiao-Li Ge, and Xu-Hui Wang, and Juan-Hong Shi, and Xiao-Qiang Wang
July 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Shi-Ting Li, and Jing Pan, and Xu-Ming Hua, and Hong Liu, and Sa Shen, and Jia-Fu Liu, and Bin Li, and Bang-Bao Tao, and Xiao-Li Ge, and Xu-Hui Wang, and Juan-Hong Shi, and Xiao-Qiang Wang
November 2018, Journal of diabetes,
Shi-Ting Li, and Jing Pan, and Xu-Ming Hua, and Hong Liu, and Sa Shen, and Jia-Fu Liu, and Bin Li, and Bang-Bao Tao, and Xiao-Li Ge, and Xu-Hui Wang, and Juan-Hong Shi, and Xiao-Qiang Wang
January 2008, Circulation,
Shi-Ting Li, and Jing Pan, and Xu-Ming Hua, and Hong Liu, and Sa Shen, and Jia-Fu Liu, and Bin Li, and Bang-Bao Tao, and Xiao-Li Ge, and Xu-Hui Wang, and Juan-Hong Shi, and Xiao-Qiang Wang
August 2000, European journal of pharmacology,
Shi-Ting Li, and Jing Pan, and Xu-Ming Hua, and Hong Liu, and Sa Shen, and Jia-Fu Liu, and Bin Li, and Bang-Bao Tao, and Xiao-Li Ge, and Xu-Hui Wang, and Juan-Hong Shi, and Xiao-Qiang Wang
January 2020, F1000Research,
Shi-Ting Li, and Jing Pan, and Xu-Ming Hua, and Hong Liu, and Sa Shen, and Jia-Fu Liu, and Bin Li, and Bang-Bao Tao, and Xiao-Li Ge, and Xu-Hui Wang, and Juan-Hong Shi, and Xiao-Qiang Wang
August 2001, Brain research,
Copied contents to your clipboard!